Our Mission

To advance knowledge and rapidly translate discovery into exceptional, personalized cancer care for our patients.Learn more about the Cancer Center learn more

06/13/2015: 9th International Oncolytic Virus Therapeutics Conference

From June 13-16, 2015, two of the Harvard-affiliated institutions, Brigham and Women’s Hospital and Massachusetts General Hospital will host OVC Boston, the 9th International Oncolytic Virus Therapeutics Conference at the historic Boston Park Plaza Hotel.

05/22/2015: Tarbell lecture focuses on patient-centered hospital advancement

Kate Walsh, president and CEO of Boston Medical Center, was the keynote speaker at the seventh annual Nancy J. Tarbell, MD, Faculty Development Lectureship on May 13.

05/19/2015: Partnerships promote education, awareness

The MGH recently participated in two opportunities aimed at raising awareness for early detection and proper treatment of cancer.

05/19/2015: A beautiful thank you

2015 marks the fifth year that the national director of creative artistry for Giorgio Armani, Tim Quinn, has come to the MGH during Nurses Week to provide a day of makeovers for the Cancer Center nursing staff.

05/18/2015: New device successfully captures metastasis-associated circulating tumor cell clusters

The latest version of a microfluidic device for capturing rare circulating tumor cells is the first designed specifically to capture clusters of two or more cells, rather than single cells. Recent studies by MGH investigators and others have suggested that CTC clusters are significantly more likely to cause metastases than single circulating tumor cells.

05/11/2015: Combined radiation and hormonal therapy improves survival in node-positive prostate cancer

A new study finds that men with prostate cancer that has spread to nearby lymph nodes can benefit from the addition of radiation therapy to treatments that block the effects of testosterone.

05/09/2015: 2015 Nobel Prize Laureate Summit on Biomedical Sciences: Frontiers in Cancer Research

The 2015 NPLS will focus on Frontiers in Cancer Research, and cover some of the latest advances in the understanding and treatment of cancer. The conference brings together some of the world’s leading scientists and physicians who have made dramatic breakthroughs in cancer therapy. Massachusetts General Cancer Center Director, Dr. Daniel Haber, is a keynote speaker.

05/09/2015: 2015 Nobel Prize Laureate Summit on Biomedical Sciences: Frontiers in Cancer Research

The 2015 NPLS will focus on Frontiers in Cancer Research, and cover some of the latest advances in the understanding and treatment of cancer. The conference brings together some of the world’s leading scientists and physicians who have made dramatic breakthroughs in cancer therapy. Mass General Hospital Cancer Center Director, Dr. Daniel Haber, is a keynote speaker.

05/08/2015: Molecular tumor diagnosis with a smartphone

A device developed by MGH investigators may bring rapid, accurate molecular diagnosis of tumors and other diseases to locations lacking the latest medical technology

04/29/2015: Rociletinib shows promising activity against treatment-resistant EGFR-mutated lung cancer

A new targeted therapy drug against EGFR-mutation driven lung tumors that have become resistant to current therapies shows activity against the most common resistance mutation, significantly improving outcomes for patients.

04/24/2015: MGH Cancer Center receives second Stand Up to Cancer Dream Team award

Stand Up to Cancer (SU2C) and the American Cancer Society (ACS) announced the formation of a new Dream Team to tackle the problem of lung cancer during the annual meeting of the American Association of Cancer Research (AACR) held April 20 in Philadelphia.

04/20/2015: New SU2C-American Cancer Society Lung Cancer Dream Team Announced

Jeffrey A. Engelman, MD, PhD, associate professor of medicine at Harvard Medical School and director of thoracic oncology at Massachusetts General Hospital Cancer Center, will be leader of a $20 million Dream Team to attack the number one cancer killer in America, lung cancer.

04/13/2015: Smartphone-based device could provide rapid, low-cost molecular tumor diagnosis

A device developed by MGH investigators may bring rapid, accurate molecular diagnosis of tumors and other diseases to locations lacking the latest medical technology.

03/17/2015: Genetic background determines whether aspirin/NSAIDS will reduce colorectal cancer risk

An analysis of genetic and lifestyle data from 10 large epidemiologic studies confirmed that regular use of aspirin or other non-steroidal anti-inflammatory drugs appears to reduce the risk of colorectal cancer in most individuals. The study also found that a few individuals with rare genetic variants do not share this benefit.

02/06/2015: Bone Marrow Transplant team opens new lab

A ceremonial ribbon-cutting ceremony was held Jan. 29 to officially open the new Bone Marrow Transplant Cellular Processing Laboratory.

01/27/2015: Updated Opening Information

At this time, the Cancer Center will be open at 10am on Wednesday, January 28. If you have an appointment scheduled before 10am, a staff member will be in contact with you to reschedule your appointment.

01/15/2015: Study identifies new targeted treatment strategy for some aggressive cancers

Researchers from the Massachusetts General Hospital (MGH) Cancer Center and Boston University School of Medicine (BUSM) have identified the first potential treatment targeting a pathway by which several aggressive tumors maintain their ability to proliferate.

12/16/2014: Single genetic abnormality accelerates, removes the brakes on Ewing sarcoma tumor growth

The genetic abnormality that drives the bone cancer Ewing sarcoma operates through two distinct processes – both activating genes that stimulate tumor growth and suppressing those that should keep cancer from developing.

12/12/2014: Everyday extraordinary

Created and supported by the Mass General Cancer Center, the one hundred is an awareness and fundraising initiative that celebrates hope in the cancer community.

12/05/2014: Catwalk for cancer

Daniel A. Haber, MD, PhD, director of the MGH Cancer Center, and Kate Robbins, a 10-year survivor of advanced stage lung cancer, were among the many models who walked the runway at the Friends of the Mass General Cancer Center Fall Benefit: Couture for Cancer Care at the Revere Hotel in Boston.

11/17/2014: Gatsby gala

The Julie Fund for Women’s Cancers celebrated its 10th anniversary with a Great Gatsby-themed gala Nov. 1 at The Fairmont Copley Plaza

11/13/2014: Direct drug screening of patient biopsies could overcome resistance to targeted therapy

A new screening platform using cells grown directly from tumor biopsy samples may lead to truly individualized treatment strategies that would get around the problem of treatment resistance, which limits the effectiveness of current targeted therapy drugs.

10/10/2014: Exercise breast cancer prevention

October is Breast Cancer Awareness Month, and reminders are everywhere for women to remain vigilant about screening and maintaining a healthy lifestyle – including daily exercise. Lidia Schapira, MD, medical oncologist with the MGH Center for Breast Cancer, shares her insights on the benefits of staying fit.

10/01/2014: Breast Cancer Awareness Month 2014 at Mass General

In honor of Breast Cancer Awareness Month in October, Mass General Imaging is hosting educational events to support women's breast health. Learn more about this year's events in Boston, Waltham, Danvers, Revere and Chelsea.

09/27/2014: Crizotinib treatment effective against ROS1-positive lung cancer

Treatment with the targeted therapy drug crizotinib effectively halts the growth of lung tumors driven by rearrangements of the ROS1 gene

09/26/2014: A pitcher’s promise

Red Sox pitcher Craig Breslow walked off the baseball field and into patient rooms at MassGeneral Hospital for Children Sept. 15.

09/22/2014: Mass. General study reveals gene expression patterns in pancreatic circulating tumor cells

Analysis of circulating tumor cells in a mouse model of pancreatic cancer identified distinct patterns of gene expression in several groups of CTCs, including significant differences from the primary tumor that may contribute to the ability to generate metastases and prove to be targets for improved treatment of the deadly tumor.

09/11/2014: A non-toxic strategy to treat leukemia

A study comparing how blood stem cells and leukemia cells consume nutrients found that cancer cells are far less tolerant to shifts in their energy supply than their normal counterparts. The results suggest that there could be ways to target leukemia metabolism so that cancer cells die but other cell types are undisturbed.

09/11/2014: Russell Museum Fall Lecture Series

All MGH Russell Museum lectures are open to the public. To register, please email mghhistory@partners.org.

08/28/2014: Circulating tumor cell clusters more likely to cause metastasis than single cells

Circulating tumor cell clusters – clumps of from 2 to 50 tumor cells that break off a primary tumor and are carried through the bloodstream – appear to be much more likely to cause metastasis than are single CTCs, according to a study from investigators at the MGH Cancer Center.

08/15/2014: Nurses set sail

A large group of MGH Cancer Center nursing staff from Lunder 9 and 10 set out on the open sea for a summer sail in Marblehead Aug. 7 with the Haverhill-based nonprofit Sailing Heals.

07/15/2014: #1 in New England, #2 in the nation

U.S. News & World Report ranks Massachusetts General Hospital among the top hospitals in America based on our quality of care, patient safety and reputation in 16 specialties.

07/10/2014: Cultured circulating tumor cells reveal genetic profile, potential drug susceptibility of breast cancer cells

Circulating tumor cells captured with a microchip-based device developed at the MGH Center for Engineering in Medicine and the MGH Cancer Center can be cultured to establish cell lines that accurately reflect a tumor’s genetic mutation over time and changing susceptibility to therapeutic drugs.

06/20/2014: Stars shine at the one hundred

The Mass General Cancer Center hosted the seventh annual the one hundred gala on June 10.

05/16/2014: Exploring opportunities to expand cancer care

The MGH Cancer Center recently sent a team to the city of Mbarara in southwestern Uganda to explore a collaboration with the local university and hospital to build a new national referral cancer center.

05/09/2014: Beauty beyond skin deep

No one works a room quite like Tim Quinn. The celebrity makeup artist and national director of Creative Artistry for Giorgio Armani Beauty has a gift for making a woman look and feel beautiful and he brought his gift to the MGH.

04/25/2014: Success for Mass General Marathon Teams

The 2014 Boston Marathon marked a triumphant return for the Mass General Marathon teams.

04/23/2014: Study Shows Aspirin Can Reduce Colorectal Cancer Risks for Those with Specific Gene

Researchers from MGH, Dana-Farber Cancer Institute and Case Western Reserve School of Medicine have shown that aspirin’s previous reported ability to reduce the risk of colorectal cancer applies only to individuals with high levels of a specific gene product in their colons.

04/18/2014: Why we run

MGH marathon runners — in their own words

04/10/2014: Researchers identify transcription factors distinguishing glioblastoma stem cells

The activity of four transcription factors appears to distinguish the small proportion of glioblastoma cells responsible for the aggressiveness and treatment resistance of the deadly brain tumor. The findings identify molecular circuits that may be targeted by new therapeutic approaches

04/04/2014: Cancer Center physicians honored

The Henri and Belinda Termeer Center for Targeted Therapies in the MGH Cancer Center has three new endowed leadership positions.

03/26/2014: New drug successfully treats crizotinib-resistant, ALK-positive lung cancer

A new drug called ceritinib appears to be effective against advanced ALK-positive non-small cell lung cancer, both in tumors that have become resistant to crizotinib and in those never treated with the older drug.

03/12/2014: Cancer Research Award

2014 Massachusetts General Hospital Award in Cancer Research given to Hans Clevers, MD, PhD.

03/07/2014: Giving back, one step at a time

Leeds Pierce was 10 years old when her father ran the Boston Marathon in her honor as part of the Mass General Marathon Team “Fighting Kids Cancer ... One Step at a Time.”

03/06/2014: The Personalized Medicine Approach to Treating Myeloma

Dr. Noopur Raje, Director of the Center for Multiple Myeloma at Massachusetts General Hospital Cancer Center, discusses the results of a practice changing trial, presented at the American Society of Hematolog (ASH) Conference, confirming the continuous use of lenalidomide in the newly diagnosed myeloma patient.

03/05/2014: Novel cancer vaccine holds promise against ovarian cancer, mesothelioma

A novel approach to cancer immunotherapy may provide a cost-effective weapon against some of the most deadly tumors, including ovarian cancer and mesothelioma. A protein engineered by MGH investigators to combine a molecule targeting a tumor antigen with an immune-function stimuating protein prolonged survival in animal models of both tumors.

02/28/2014: Nurses on the run

Six nurses on the Blake 12 Intensive Care Unit are planning to run the 2014 Boston Marathon – five for charity teams and one as a qualified runner.

02/03/2014: Gene mutation defines brain tumors that benefit from aggressive surgery

A new study has found that patients with malignant astrocytoma – the most common malignant brain tumor – whose tumors carry a specific genetic mutation benefit greatly from surgical removal of the largest possible amount of tumor.

01/21/2014: A Mass General breast technologist tells her patients why she never misses a mammogram

Dolores Dunne LeGeyt is a Mass General breast imaging technologist who has never missed a mammogram. She is also a breast cancer survivor.

01/21/2014: Shutting down myeloma growth

Shutting down myeloma growth by changing the soil where it grows with Dr. Noopur Raje of Massachusetts General Hospital Cancer Center

01/15/2014: 'Barcode' profiling enables analysis of hundreds of tumor marker proteins at once

A new technology developed at the Massachusetts General Hospital Center for Systems Biology allows simultaneous analysis of hundreds of cancer-related protein markers from miniscule patient samples gathered through minimally invasive methods.

01/12/2014: Multi-institutional team finds targetable mutation in rare brain tumor

A team led by investigators from MGH, Brigham and Women's Hospital and the Broad Institute has found that a gene mutation associated with several types of cancer also may be responsible for a rare but debilitating brain tumor called papillary craniopharyngioma.

01/10/2014: Graubert appointed first incumbent of the Hagler Family Chair

Timothy A. Graubert, MD, program director for Hematologic Malignancies at the MGH Cancer Center, was honored Nov. 18 with the first Hagler Family Chair in Hematologic Malignancies.

01/06/2014: Tiny Technology Enables Improved Detection of Circulating Tumor Cells

The ability to detect circulating tumor cells as they travel through the blood can play an important role in early diagnosis, characterization of cancer subtypes, treatment monitoring and metastasis.

12/10/2013: Spinal Metastases & Stereotactic Radiosurgery

Radiosurgery has shifted the paradigm of treating patients by minimizing the morbidity of conventional surgery and, focusing on tumor control.

12/06/2013: Clinical waste may prove valuable for monitoring treatment response in ovarian cancer

MGH investigators have developed a microchip-based device that can isolate and identify tumor cells found in ascites – an accumulation of fluid in the abdomen that often occurs in abdominal cancers – potentially simplifying the monitoring of treatment response in ovarian cancer and other malignancies.

11/20/2013: Tiny antisense molecules increase 'good cholesterol' levels in obese primates

A strategy developed by MGH-based investigators to increase levels of beneficial high-density lipoprotein has been shown for the first time to be effective in non-human primates.

11/04/2013: Imaging studies may predict tumor response to anti-angiogenic drugs

Advanced imaging techniques may be able to distinguish which patients' tumors will respond to treatment with anti-angiogenic drugs and which will not.

10/11/2013: Shaping the delivery of care

For more than a decade, the MGH Patient and Family Advisory Councils have provided communication vehicles for patients and families to share their experiences.

10/01/2013: Blood-pressure drug may help improve cancer treatment

Use of existing, well-established hypertension drugs could improve the outcome of cancer chemotherapy by opening up collapsed blood vessels in solid tumors.

09/27/2013: Run Raises Hope for Kids’ Cancer

A record number of participants joined the annual Four Seasons Run of Hope on September 8th to raise awareness for pediatric cancer care and research at MassGeneral Hospital for Children.

09/18/2013: Study shows colonoscopy better than sigmoidoscopy in protecting against colorectal cancer

A new study finds that colonoscopy appears to reduce the risk of developing or dying from colorectal cancer more powerfully than does sigmoidoscopy, a similar procedure that examines only a portion of the colon. The investigation also identifies molecular features that may help explain tumors that are diagnosed despite an individual's having recently undergone colonoscopy.

09/11/2013: Gene-expression-based biomarker predicts long-term risk of breast cancer recurrence

A comparison of three methods of predicting recurrence risk in women treated for estrogen-receptor-positive breast cancer finds that only the breast cancer index – a biomarker based on the expression levels of seven tumor-specific genes – accurately identifies patients who continue to be at risk after five years of estrogen-blocking treatment.

08/31/2013: Uncovering the Life of Padihershef

Earlier this year MGH received an anonymous gift for the restoration of Padihershef. This generous funding launched a multi-phase conservation and research project that delves into many aspects of the life and death of the hospital's mummy.

08/18/2013: New MR analysis technique reveals brain tumor response to anti-angiogenesis therapy

A new way of analyzing data acquired in MR imaging appears to be able to identify whether or not tumors are responding to anti-angiogenesis therapy, information that can help physicians determine the most appropriate treatments and discontinue ones that are ineffective.

08/02/2013: MGH Cancer Center offers Lung Screenings

On July 29, the U.S. Preventive Services Task Force (USPSTF) announced its recommendation for screening high-risk patients for lung cancer with low-dose CT scans (LDCTs).

07/16/2013: #1 in New England, #2 in the nation

U.S. News & World Report ranks Massachusetts General Hospital among the top hospitals in America based on our quality of care, patient safety and reputation in 16 specialties.

07/15/2013: Longfellow Bridge Renovations

Beginning July 20, the Mass Department of Transportation is going to begin a multi-year renovation project on the Longfellow Bridge, the bridge that connects our Mass General campus at Charles Street with Cambridge.

06/29/2013: Let’s Talk: The Changing Landscape of Cancer Care

Advances in understanding cancer and its treatment are in the news almost every day. Cancer research is being translated into new treatments more rapidly than ever before. People are living with cancer longer, but this positive change comes with new challenges.

06/28/2013: Biomarker predicts risk of breast cancer recurrence after tamoxifen treatment

A biomarker reflecting expression levels of two genes in tumor tissue may be able to predict which women treated for estrogen-receptor-positive breast cancer should receive a second estrogen-blocking medication after completing tamoxifen treatment.

06/14/2013: Honorees shine at sixth annual MGH Cancer Center gala

On June 5, the MGH Cancer Center hosted the sixth annual the one hundred gala. Hosted by actor and Newton native John Krasinski, the fundraiser attracted some 900 attendees, raised more than $1.3 million, and honored 100 individuals and organizations for their commitment and contributions to the fight against cancer.

06/06/2013: Center for Cancer Research 25th Anniversary Research Symposium

The Center for Cancer Research celebrates it's 25th Anniversary with a Research Symposium, Thursday, June 6, 2013. Starr Center, Simches Building, 185 Cambridge Street, Boston, MA. All are welcome.

06/06/2013: Award in Cancer Research

Mass General Hospital Award in Cancer Research presented to James P. Allison, PhD

06/03/2013: MGH-led studies shed new light on targeted lung cancer therapy

Research teams led by Massachusetts General Hospital (MGH) Cancer Center investigators are publishing two important studies regarding use of the targeted cancer drug crizotinib for treatment of advanced lung cancer driven by specific genetic mutations.

05/24/2013: Getz, Raje honored with endowed chairs in oncology

The MGH honored two staff members this month as inaugural recipients of endowed chairs in oncology, both made possible thanks to the generosity of an anonymous donor.

05/20/2013: Genetic diversity within tumors predicts outcome in head and neck cancer

A new measure of the heterogeneity – the variety of genetic mutations – of cells within a tumor appears to predict treatment outcomes of patients with the most common type of head and neck cancer.

05/17/2013: Cancer survivor stays positive by giving back to others

Patient's dedication, determination helps her in her battle against cancer.

05/10/2013: Cancer Center names the one hundred honorees

The MGH Cancer Center’s announces the one hundred honorees for 2013, recognizing outstanding individuals or groups who have made or are making a significant difference in the fight against cancer.

04/18/2013: Three Mass. General researchers among recipients of Top 10 Clinical Research Achievement awards

Three projects led by Massachusetts General Hospital (MGH) investigators have been named among the Clinical Research Forum's Top 10 Clinical Research Achievements of 2012.

04/15/2013: Gene-expression signature may signify risk for recurrence, metastasis in prostate cancer

A team led by MGH researchers has identified a genetic signature that may reflect the risk of tumor recurrence or spread in men surgically treated for prostate cancer. If confirmed, the genetic risk index also may help distinguish tumors that require aggressive treatment from those that can safely be monitored.

04/12/2013: Cancer Center fellowship program receives $1M gift

The MGH Cancer Center has received a $1.05 million gift from Sovereign Bank, N.A., a division of Santander Holdings USA, in support of its Hematology/Oncology Research Fellowship Fund.

04/07/2013: Next-generation PI3 Kinase Inhibitor Demonstrated Early Efficacy, Safety

GDC-0032, a potent, next-generation PI3 kinase inhibitor, demonstrated early signs of efficacy for patients with cancers driven by mutations in the PI3 kinase alpha gene, according to first in-human results presented at the AACR Annual Meeting 2013.

04/03/2013: Third-generation device significantly improves capture of circulating tumor cells

A new system for isolating rare circulating tumor cells – living solid tumor cells found at low levels in the bloodstream – shows significant improvement over previously developed devices and does not require prior identification of tumor-specific target molecules.

03/11/2013: Mass General and NCAA coaches promote colorectal cancer screening

Massachusetts General Hospital is partnering with the American Society of Colon and Rectal Surgeons, and Coaches vs. Cancer to promote screening and treatment for colorectal cancer.

03/08/2013: BRAF inhibitor treatment causes melanoma cells to shift how they produce energy

A multi-institutional study has revealed that BRAF-positive metastatic malignant melanomas develop resistance to treatment with drugs targeting the BRAF/MEK growth pathway through a major change in metabolism. The findings suggest a strategy to improve the effectiveness of currently available targeted therapies.

02/28/2013: Study identifies growth factor essential to the most common malignant pediatric brain tumor

A multi-institutional team led by MGH researchers has identified a molecular pathway that appears to be essential for the growth and spread of medulloblastoma, the most common malignant brain tumor in children.

01/31/2013: Transition in cell type parallels treatment response, disease progression in breast cancer

A process that normally occurs in developing embryos – the changing of one basic cell type into another – has also been suspected of playing a role in cancer metastasis. Now a study from MGH Cancer Center researchers has associated this process, called epithelial-mesenchymal transition, with disease progression and treatment response in breast cancer patients.

01/23/2013: Mass General Cancer Center Priorities Fund Advances Research that Will Help Patients

Mass General’s goal is to encourage and support research and programs that will make a difference in lives of patients.

12/24/2012: Improved Understanding and Management of Pancreatic Cancer

Efforts at Massachusetts General Hospital Cancer Center are underway to address the need for more effective treatment approaches for locally advanced and metastatic disease.

12/06/2012: Protein controlling glucose metabolism also a tumor suppressor

A protein known to regulate how cells process glucose also appears to be a tumor suppressor, adding to the potential that therapies directed at cellular metabolism may help suppress tumor growth.

11/09/2012: A special first dance

As a child suffering from Ewing’s sarcoma, a type of bone cancer, Marcela Gaviria complained to her surgeon, Dempsey Springfield, MD, that she would never get married.

11/02/2012: Toy Box brings joy to children with cancer

Three- year-old Hope Bolster and her sister, Quinn, were always eager for the toy closet to open. Toy day was their reward for making it through another week of Hope’s proton beam therapy, a type of radiation she was receiving to treat her cancer.

11/01/2012: Combining antiangiogenesis and anti-HER2 drugs may improve survival of breast cancer patients with brain metastases

Adding an angiogenesis inhibitor to treatment with a HER2-inhibiting drug could improve outcomes for patients with HER2-positive breast cancer who develop brain metastases.

10/31/2012: Unexpected factor contributes to melanoma risk in red-haired, fair-skinned individuals

The elevated risk of melanoma among people with red hair and fair skin may be caused by more than just a lack of natural protection against ultraviolet radiation. Resarchers at the MGH Cutaneous Biology Research Center and Cancer Center have found that the type of skin pigment predominantly found in red-haired, fair-skinned individuals may itself contribute to the development of melanoma.

10/26/2012: A lasting friendship for two families

Twenty-five years after their sons were diagnosed with leukemia, the Masserys and Donnellans remain close friends -- and the two young men are now long cancer free.

10/26/2012: Toy Box brings joy to children with cancer

In November 2011, Hope Bolster, 2, was diagnosed with rhabdomyosarcoma, a form of muscle cancer.

10/19/2012: Ryan appointed chief of Hematology/Oncology

On Oct. 12, the Department of Medicine and the Cancer Center announced the appointment of David Ryan, MD, as the new chief of Hematology/Oncology at the MGH. Ryan, who succeeds Jose Baselga, MD, PhD, joined the MGH Cancer Center in 1998.

10/05/2012: Celebrating Amazing Moms

A Sept. 9 celebration at the Liberty Hotel honored a special group of mothers – moms of childhood cancer survivors and childhood cancer patients currently in treatment at MassGeneral Hospital for Children.

09/30/2012: Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer

The results of a new phase III trial show that crizotinib, a targeted therapy, is a more effective treatment than standard chemotherapy for patients with advanced, ALK-positive lung cancer.

09/29/2012: Combination of targeted treatment drugs delays resistance in melanoma patients

Combined treatment with two drugs targeting different points in the same growth-factor pathway delayed the development of treatment resistance in patients with BRAF-positive metastatic malignant melanoma.

08/03/2012: MGH Award in Cancer Research presented

Craig B. Thompson, MD, president and chief executive officer of Memorial Sloan-Kettering Cancer Center, received the seventh annual MGH Award in Cancer Research on June 28.

07/17/2012: Massachusetts General Hospital Ranked #1 in the Nation on U.S. News & World Report Honor Roll

Massachusetts General Hospital has moved into the number one spot on the 2012-13 U.S. News & World Report’s “America’s Best Hospitals” list.

07/16/2012: Innovations in Breast Cancer Treatment

As part of the multidisciplinary approach to breast cancer treatment, Mass General Cancer Center patients receive care from an integrated team of pathologists, radiologists, and medical, surgical, and radiation oncologists.

07/16/2012: An Interview with Jose Baselga, MD, PhD

Particularly interested in breast cancer, Dr. Baselga has been deeply involved in the development of new targeted therapies that attack cancer at the molecular level.

07/13/2012: International honor

Bruce Chabner, MD, director of Clinical Research for the MGH Cancer Center, was the recipient of an honorary Doctorate of Medical Sciences from the Queen’s University of Belfast, Northern Ireland.

07/13/2012: Annual Julie Fund Walk

Some 300 individuals gathered along the Charles River June 16 for the seventh annual Julie Fund Walk.

07/04/2012: Tumor microenvironment helps skin cancer cells resist drug treatment

New research by a team from the Broad Institute, Dana-Farber Cancer Institute, and Massachusetts General Hospital suggests that how cancer evade drug treatment may depend on the interplay between tumor cells and their healthy counterparts.

07/01/2012: Potential treatment target identified in an animal model of pancreatic cancer

Detailed analysis of genes expressed in circulating tumor cells – cells that break off from solid tumors and travel through the bloodstream – has identified a potential treatment target in metastatic pancreatic cancer.

06/20/2012: Nurse goes beyond the extra mile for former patient

When a dying patient asked oncology nurse Kristin Beauparlant to take up her efforts to bicycle and raise funding for cancer research, Beauparlant couldn't say no. On June 15 through 17, Beauparlant and the patient's widow rode 180 miles and raised $34,000 to support ovarian cancer education and research at the MGH.

06/15/2012: Bangladesh Minister of Health visits MGH

On June 8, the Bangladesh Minister of Health and Family Welfare, A. F. M. Ruhal Haque, MBBS, met with MGH staff members to discuss longstanding collaborations between Bangladesh health care services and various MGH departments.

06/15/2012: 'the one hundred' gala raises $1 million

The flash of cameras and a red carpet entrance greeted guests at the Westin Boston Waterfront June 7 as the MGH Cancer Center celebrated its fifth annual the one hundred gala.

05/25/2012: 2012 Research Scholars announced

The second group of MGH Research Scholars – recipients of unrestricted five-year grants to support innovative investigations – was announced at the hospital’s Research Advisory Council (RAC) annual meeting on May 11.

05/21/2012: Granite State Ride Brings Together the Community

Cancer changes a family’s life, and without support is unbearable. That is what Bruce and Laurie Taylor believe and why they and their friends from The Timberland Company created the Granite State Quest, a community bike ride through southern New Hampshire that raises money for pediatric cancer research at Massachusetts General Hospital for Children.

05/11/2012: Navigating the cancer journey

The MGH Cancer Center and its peer support program, The Network for Patients and Families, hosted the April 28 event, “Cancer in the Family: Living with Uncertainty."

05/04/2012: Singers lend voices in support of Cancer Center

Singer-songwriter Ben Folds, far right, was the headliner and host at "A Cappella Palooza!" a concert to benefit the MGH Cancer Center.

05/04/2012: Hearts of gold

On April 26, members of the MGH Cancer Center and Patient Care Services gathered to celebrate the establishment of the Jill Nelson Burke, NP, Advanced Practice Nursing Award.

04/04/2012: Young Patient Inspires Marathon Team Runner’s Determination to Finish

Sutanuka Lahiri plans to run through her pain to finish the Boston Marathon. Lahiri injured her leg while training and had to rest for several weeks. But she is determined to complete the race to honor 3-year-old Henry Geis, who is receiving treatment for leukemia at MassGeneral Hospital for Children. Lahiri has been raising money for the hospital through her participation in the Mass General Marathon Team. The team is made possible by a partnership with John Hancock Financial.

03/28/2012: The path to personalized cancer treatment

In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalized approach to cancer treatments.

02/24/2012: Music In Medicine

Claudius Conrad, MD, PhD, Director of Music in Medicine of the Department of Surgery and the Benson Henry Institute for Mind Body Medicine, played the works of Chopin, Mozart and Schumann and discussed the therapeutic benefits of music as it relates to surgery.

02/16/2012: MGH Cancer Center team identifies potential treatment target for KRAS-mutated colon cancer

Researchers from the MGH Cancer Center have identified a new potential strategy for treating colon tumors driven by mutations in the KRAS gene, which usually resist both conventional and targeted treatments.

02/03/2012: Dyson appointed scientific director

Nick Dyson, PhD, has been appointed scientific director of the Mass General Cancer Center.

01/31/2012: Mass. General study defines a new genetic subtype of lung cancer

MGH Cancer Center investigators have defined the role of a recently identified gene abnormality – rearrangements in the ROS1 gene – in non-small-cell lung cancer, the leading cause of cancer death in the U.S. They also show that these tumors can be treated with crizotinib and describe the remarkable response of one patient to such treatment.

01/18/2012: Novel gene mutations associated with bile duct cancer

Investigators at the MGH Cancer Center have identified a new genetic signature associated with bile duct cancer, a usually deadly tumor for which effective treatment currently is limited.

01/16/2012: Combining two anti-HER2 drugs may provide better preoperative breast cancer treatment

Using two drugs that inhibit the growth factor HER2 for preoperative treatment of early-stage HER2-positive breast cancer appears to have better results than treatment with a single agent.

12/16/2011: Mass General-led Breast Cancer Studies Received early New England Journal of Medicine Publication

Two New England Journal of Medicine papers reporting the results of separate Phase III clinical trials for the treatment of advanced breast cancer recently received early, online first release because the studies were presented at the December 2011 CTRC-AACR San Antonio Breast Cancer Symposium.

12/01/2011: Mass. General study finds amplification of multiple cell-growth genes in some brain tumors

A small percentage of the deadly brain tumors called glioblastomas, which usually resist treatment with drugs targeting mutations in cell-growth genes, appears to contain extra copies of two or three of these genes at the same time. The surprising discovery has major implications for the understanding of tumor biology and for targeted cancer therapies.

11/18/2011: Patriots touch down at MGH

New England Patriots Nate Solder and Brandon Deaderick – as well as former Patriot Thomas Welch, who signed with the Buffalo Bills Nov. 17 – made a surprise visit Nov. 8 to patients at MassGeneral Hospital for Children and the MGH Cancer Center’s Infusion Unit.

11/15/2011: Denosumab delays development of prostate cancer bone metastasis

An international clinical trial has found that treatment with a drug that suppresses the normal breakdown of bone can delay the development of bone metastases in men with prostate cancer.

11/13/2011: Newly identified gene mutation adds to melanoma risk

A major international study has identified a novel gene mutation that appears to increase the risk of both inherited and sporadic cases of malignant melanoma, the most deadly form of skin cancer. The identified mutation occurs in the gene encoding MITF, a transcription factor that induces the production of several important proteins in melanocytes, the cells in which melanoma originates.

10/28/2011: From the Tumor Clinic to the Termeer Center

The MGH Tumor Clinic – the first clinic of its kind at a general hospital – was established in 1925 and led by George W. Holmes, MD, chief of the X-ray Department, who brought together staff from various disciplines to discuss cancer cases in which radiation had proved effective when the traditional treatment of surgery had failed.

10/21/2011: ‘This is my thank you’

Fifteen-year-old Mike Duffy III came to the MGH on Oct. 13 to say thank you to the physicians who saved his father’s life.

10/03/2011: Ovarian Cancer Survivors Course

A recap of the Ovarian Cancer Survivors Course

10/03/2011: Staff Snapshot

Kathleen Gill-Bazazi: Manager/Buyer for Images Oncology Boutique North Shore and Boston; Manager of The General Hair Care in Boston.

09/28/2011: New Hope for Cancer Patients

For a number of years the Mass General Cancer Center has been at the forefront of the promising field of targeted therapy, in which treatment is tailored to attack specific genetic mutations responsible for an individual patient’s tumor. A major gift of $10 million from Henri and Belinda Termeer, announced Sept. 13, will enable the Cancer Center to expand its efforts in this area through the creation of the Henri and Belinda Termeer Center for Targeted Therapies.

09/26/2011: Overcoming Drug Resistance to Targeted Cancer Therapies

A concerted effort is under way at the Mass General Cancer Center to understand why and how cancer cells become resistant to targeted therapies. (From Advances Fall 2011 issue.)

09/13/2011: News about the Henri and Belinda Termeer Center for Targeted Therapies

Read the latest news coverage about the Henri and Belinda Termeer Center for Targeted Therapies

08/11/2011: Mass General Imaging introduces CT lung-cancer screening

Research shows a clear benefit for CT lung-cancer screening among individuals who meet strict criteria. Patients and referrers should understand both the benefit and the potential for false positive results.

07/19/2011: MGH ranks #2 in nation

MGH ranks #2 in 2011-2012 U.S. News & World Report "Best Hospitals" rankings

07/13/2011: Large clinical trial shows short-term hormone therapy plus radiation increases survival for men with early-stage prostate cancer

Short-term hormone therapy given in combination with radiation therapy for men with early-stage prostate cancer increases their chance of living longer and not dying from the disease, compared with patients who receive the same radiation therapy alone.

07/01/2011: The Wonder of Lunder

An update on Mass General’s new Lunder Building, and what it will mean for the Cancer Center

07/01/2011: Healthy Grilling

From barbecue season through tailgating time, grilling is more of a lifestyle than a method of cooking food. It can be a delicious part of healthy living if you follow these tips to maximize flavor while minimizing your cancer risk.

07/01/2011: Connections

Lisa Marie Doyle, RN, Staff Nurse, Gynecology Oncology, Bigelow 7

07/01/2011: Breakthroughs from ASCO

Cancer Center investigators and physician-scientists share promising research and treatment developments in breast cancer, melanoma and more.

07/01/2011: A Powerful Partnership

The Mass General Cancer Center teams up with the American Cancer Society to increase education, awareness and funding to fight cancer.

06/10/2011: Cancer Center celebrates the one hundred

MGH Hotline 6.10.11 One individual can make an incredible difference for a patient with cancer.

06/10/2011: MGH launches new award to support research

MGH Hotline 6.10.11 Selected from among 115 applications from across the MGH research community, the inaugural MGH Research Scholars recently were announced at the annual meeting of the MGH Research Advisory Council (RAC).

06/02/2011: Healthy Picks

June marks the start of the best time of year to find the widest variety of delicious, nutritious fruits and vegetables in New England. If you’re looking for the healthiest produce for the best prices, or wondering what terms like “organic”, “local” and “natural” really mean to you, here’s a quick guide to making the best summer selections.

06/02/2011: Summer of Support

As warmer weather approaches, the Cancer Center community looks forward to a summer filled with informational and inspirational events. There’s something for everyone, so get involved!

06/02/2011: Target: Melanoma

The latest news on melanoma treatment and research from the new issue of Synergy magazine and a recent edition of the television program Chronicle.

06/02/2011: Staff Snapshot

David Apostol, Senior Project Specialist

05/20/2011: MGH Cancer Center awards research prize

The MGH Cancer Center presented its annual MGH Award in Cancer Research on April 8 to Michael R. Stratton, MD, PhD, director of the Wellcome Trust Sanger Institute.

05/02/2011: Carlos Fernandez-Robles, MD, honored as part of the one hundred

Since joining the Bone Marrow Transplant Service at Mass General in 2009, Psychiatric Oncologist Carlos Fernandez-Robles, MD, has dramatically expanded its inpatient psychiatric consultation services.

05/02/2011: Fredrica Preston, NP, honored as part of the one hundred

From 1995 to 2010, Fredrica (Ricky) Preston, RNC, NP, AOCN, was the sole nurse practitioner in medical oncology at the Mass General/North Shore Cancer in Danvers, Mass. With great commitment, compassion and knowledge, she quickly established an advanced practice that enables North Shore residents to access exemplary cancer care without traveling to Boston.

05/02/2011: Shedding Light on Sun Protection

It’s important to remember that May’s longer days and more intense sun can also leave us vulnerable to skin damage as we enjoy outdoor activities. Protect yourself by following these simple tips.

04/28/2011: Nicholas Dyson, PhD, honored as part of the one hundred

Dr. Dyson, a senior scientist at the Center for Cancer Research, has made breakthroughs in our understanding of the way cells divide, whether it is the regulated division of a normal cell or the abnormal proliferation of a malignant cancer.

04/22/2011: MGHfC patient first to join hospital marathon team

On Marathon Monday, April 18, one MassGeneral Hospital for Children (MGHfC) patient reached another milestone in her recovery from cancer

04/22/2011: Celebrating prize-winning MGH research

The presentation of the MGH's top research prizes was a highlight of the April 13 Celebration of Science, held in conjunction with the annual Scientific Advisory Committee meeting.

04/22/2011: SAC meeting

The 64th meeting of the MGH Scientific Advisory Committee (SAC) on April 14 celebrated key accomplishments of MGH investigators, past and present, and examined strategies for meeting the challenges currently facing the academic biomedical research community.

04/08/2011: SAC meeting to honor past scientific leadership, address current challenges

ALL MGHERS are invited to attend the 2011 meeting of the MGH Scientific Advisory Committee (SAC), which will commemorate the hospital’s bicentennial with a look back at significant research accomplishments of MGH investigators and examine challenges facing today’s research community.

04/05/2011: Clinical Conversations

Being an empowered patient sometimes means asking the tough questions. Esophageal cancer survivor, Fritz Ferbert, is so glad he did.

04/04/2011: Stand Up To Cancer

Sridhar Ramaswamy, MD, awarded a Research Innovation Grant to fund his lab’s work on the mechanisms of cancer cell survival, metastasis, drug resistance, and dormancy.

03/23/2011: Mass. General study reveals how lung cancers evolve in response to targeted treatment

A detailed analysis of lung tumors that became resistant to targeted therapy drugs has revealed two previously unreported resistance mechanisms. The report also describes how the cellular nature of some tumors can change in response to treatment and finds how resistance-conferring mutations can disappear after treatment is discontinued.

03/23/2011: Epigenomic findings illuminate veiled variants

Genes make up only a tiny percentage of the human genome, but the rest may hold vital clues about the genetic origins of disease. Using a new mapping strategy, a research team has begun to assign meaning to the regions beyond our genes and has revealed how minute changes in these regions might be connected to common diseases.

03/18/2011: Lunder Building 9 and 10 medical oncology floors

MGH Hotline 3.18.11

03/09/2011: Aspirin's ability to protect against colorectal cancer may depend on risk-associated inflammatory pathways

The reduced risk of colorectal cancer associated with taking aspirin or other nonsteroidal anti-inflammatory drugs may be limited to individuals already at risk because of elevations in a specific inflammatory factor in the blood.

03/01/2011: Breaking Barriers

The Colorectal Cancer Screening Navigator Program at Mass General Chelsea Healthcare Center is reducing disparities in screening rates among minority patients.

03/01/2011: Staff Snapshot

Oncology Nutritionist, Julia Hincman-Francavilla, MS, RD, LDN

02/18/2011: A lifesaving gift

MGH Hotline 2.18.11 The meeting of 50-year-old Erin Cortright with 28-year-old Carrie Atkins, surrounded by a team of MGH caregivers from the Bone Marrow Transplant Unit, brought tears to many eyes.

02/14/2011: Genetic Profiling Uncovers New Therapeutic Approaches to Ovarian Cancer

Advances Spring 2011 Issue. In the United States, ovarian cancer remains the deadliest of all gynecologic malignancies and the fifth leading cause of cancer death for women. The lack of an adequate early-detection screening assay is a major factor in the high fatality rate. More than 75 percent of cases present with advanced-stage disease; of these patients, fewer than 30 percent have five-year disease-free survival rates or are cured.

02/04/2011: MGH and CBS care

MGH Hotline 02.04.11 To promote awareness about the disease and the importance of self-exams, the MGH and CBS Cares are collaborating on a fun, informative public service announcement (PSA).

02/01/2011: von Hippel-Lindau Disease

December and January episodes of the television show “Grey’s Anatomy” featured a storyline about von Hippel-Lindau (VHL) disease, a rare but serious genetically-inherited condition that can cause abnormal blood vessel growth and tumor development. Gayun Chan-Smutko, MS, CGC, a genetic counselor in the Cancer Center’s von Hippel-Lindau Clinic discusses testing, screening and treatment options for VHL.

02/01/2011: A look to the future of personalized medicine

Cancer Center Associate Director and Chief of Hematology/Oncology José Baselga, MD, PhD, continues our quest to bring the most promising targeted therapies from the bench to the bedside.

02/01/2011: Staff Snapshot

Senior Genetic Counselor, Gayun Chan-Smutko, MS, CGC

02/01/2011: Pitch Perfect

TargetCancer raises awareness of rare cancers –and funds for targeted therapy research – with an ensemble of music-related efforts.

02/01/2011: Conversations from the Heart

Elizabeth Davis, MD, is a psychiatric oncologist in the Cancer Center’s Survivorship Program. She helps patients cope with both the emotional and physical side effects of cancer. Here, Dr. Davis shares tips for couples facing cancer together.

01/13/2011: Overexpression of repetitive DNA sequences discovered in common tumor cells

MGH Cancer Center researchers have discovered a previously unknown feature of common tumor cells – massive overexpression of satellite repeats, which are DNA sequences that do not code for proteins. The findings may improve understanding of tumor development and provide a new cancer biomarker.

01/11/2011: Small steps, big benefits in 2011

Whatever your goal in 2011, diet and exercise can certainly help reduce side effects of cancer treatment, improve your mood and increase overall health.

01/11/2011: Staff Snapshot

Radiation Oncology Nurse, Maryellen Lewis, RN, BSN, OCN

01/11/2011: Ringing in the New Year

Patients in Mass General Cancer Center's Francis H. Burr Proton Therapy Center ring a bell to mark the end of treatment.

01/11/2011: Paying it Forward

After nearly losing everything to stage-4 ovarian cancer, Kim Lohnes is helping others receive the care they desperately need.

01/03/2011: Mass. General Hospital enters collaboration to develop new approach to capturing circulating tumor cells

MGH has entered into a collaborative agreement with Veridex LLC to establish a center of excellence in research on circulating tumor cell technologies.

12/17/2010: Hall of Fame visit to MGH Cancer Center

MGH Hotline 12.17.10 He's considered one of the best linemen ever to play professional football, and on Dec. 2, former New England Patriots player and National Football League Hall of Fame member John Hannah helped brighten the day of patients and employees at the MGH Cancer Center when he stopped by for a visit.

12/17/2010: Handmade pillowcases bring holiday cheer

MGH Hotline 12.17.10 While having visions of sugarplum fairies, MassGeneral Hospital for Children (MGHfC) patients will be resting their heads on colorful handmade pillowcases they helped sew on Dec. 11 in the Ellison 18 Playroom with volunteers Marie Nader and Jane Cunniffe of ConKerr Cancer: A Case for Smiles.

12/14/2010: New targeted lung cancer drug produces 'dramatic' symptom improvement

A clinical trial of a potential new targeted treatment drug has provided powerful evidence that it can halt or reverse the growth of lung tumors characterized by alterations in the anaplastic lymphoma kinase (ALK) gene.

12/13/2010: Cancer Genome Research: An Update

Massachusetts General Hospital Cancer Center and the Wellcome Trust Sanger Institute's alliance in cancer genome research aims to provide novel insights into genetic features of individual tumors that may determine their response to drug treatment.

12/13/2010: Coping with Cancer at the Holidays

Tips for managing holiday stress from Liz Davis, MD, of the Cancer Center Survivorship Program

12/13/2010: Staff Snapshot

After nearly three decades with the Cancer Center, Pediatric Oncology Social Worker, Ev Malkin, LICSW is retiring this January.

12/13/2010: Cancer Center teams with the Patriots

Cancer Center teams with the Patriots for Monday Night Football awareness night as part of the season-long "Kick Cancer" initiative.

12/10/2010: Supporting brain cancer research

MGH Hotline 12.10.10 When her father John was diagnosed with a glioblastoma in June 2009, 10-year-old Elana Sargent wanted to find a way to help.

12/10/2010: Baselga first incumbent of Chabner Chair in Hematology Oncology

MGH Hotline 12.10.10 A named chair is one of the highest honors a physician may receive in his or her lifetime.

12/02/2010: Patriots and Mass General Hospital to raise awareness for colorectal cancer at Monday night's game

As part of the New England Patriots Charitable Foundation's season-long "Kick Cancer" initiative, and in partnership with Mass General Hospital, the Patriots will promote colorectal cancer awareness at the December 6 Monday night matchup at Gillette Stadium versus the New York Jets.

12/01/2010: Tumors bring their own support cells when forming metastases

A new study from MGH Cancer Center researchers finds that circulating tumor cells bring along from the original tumor site noncancerous cells that facilitate the development of metastases.

11/12/2010: Iditarod champion shares cancer story

MGH Hotline 11.12.10 Although oct. 22 was a typical autumn day with temperatures in the 60s, patients and staff were magically transported to the frozen Alaskan tundra when four-time Iditarod Trail Dog Sled Race winner Lance Mackey paid a visit to the MGH Cancer Center.

11/10/2010: Romiplostim more effective than standard care for immune thrombocytopenia

A new study finds that an FDA-approved drug to treat the rare autoimmune disorder immune thromobocytopenia (ITP) is more effective than earlier medical therapies in helping patients avoid surgical treatment and significantly improving their quality of life.

11/05/2010: Spooktacular celebrations

MGH Hotline 11.05.10 Fairies, princesses and pirates could be seen throughout campus last week as pediatric patients participated in several Halloween events hosted by MassGeneral Hospital for Children (MGHfC) and several charities.

11/01/2010: A delicate balance

Cancer Center oncology nutritionists and guest bloggers, Julia Hincman-Francavilla and Carol Sullivan, provide helpful tips for patients living with and beyond cancer.

11/01/2010: No stomach for cancer

This November, a Cancer Center patient and her organization “No Stomach for Cancer” are leading the celebration of the first National Stomach Cancer Awareness Month.

11/01/2010: Staff Snapshot

Stefanie Ryan joined the Cancer Center in 2006 as an expressive arts therapy intern from Lesley University.

11/01/2010: Researchers hone in on treatment targets for ovarian cancer

Gynecologic cancer research Program Director Michael Birrer, MD, PhD, explains how ovarian tumor discoveries in the lab are already impacting patient care.

10/27/2010: New targeted lung cancer drug produces 'dramatic' symptom improvement

A clinical trial of a potential new targeted treatment drug has provided powerful evidence that it can halt or reverse the growth of lung tumors characterized by alterations in the anaplastic lymphoma kinase (ALK) gene.

10/15/2010: A special "kick" at MGHfC

MGH Hotline 10.15.10 Despite recent changes in the New England Patriots lineup, MassGeneral Hospital for Children (MGHfC) patients remain faithful fans.

10/12/2010: Second-generation device more effective in capturing circulating tumor cells

A redesigned version of the CTC-Chip – a microchip-based device for capturing rare circulating tumor cells (CTCs) – appears to be more effective and should be easier to manufacture than the original. Called the HB-(herringbone) Chip, the new device also may provide more comprehensive and easily accessible data from captured tumor cells.

10/08/2010: Aladdin's Adventure

MGH Hotline 10.08.10 More than 400 friends and supporters of MassGeneral Hospital for Children (MGHfC) enjoyed the magical storybook theme of Aladdin's Arabian nights at the 11th annual Storybook Ball at The Castle at Park Plaza.

10/01/2010: MGH teams up with Patriots to help Kick Cancer

MGH Hotline 10.01.10 Nearly 70,000 fans pack the stands at Gillette Stadium for every New England Patriots home game, and statistically, more than one third will develop cancer in their lifetimes.

09/27/2010: The Patriots Aim to Kick Cancer

Nearly 70,000 fans pack the stands at Gillette Stadium for every Patriots home game and, statistically, far too many of them will develop cancer in their lifetimes. With support from Brigham and Women’s Hospital, Massachusetts General Hospital – the founding hospitals of Partners HealthCare – and Dana-Farber Cancer Institute, the New England Patriots Charitable Foundation has launched Kick Cancer, a season-long initiative to increase cancer awareness among Patriots fans.

09/24/2010: Stand Up to Cancer

MGH Hotline 9.24.10 The Liberty Hotel ballroom filled quickly on the evening of Sept. 10 as the MGH Development Office hosted a viewing of the Stand Up to Cancer television broadcast.

08/27/2010: Cops for Kids with Cancer

MGH Hotline 08.27.10 During what's become a summertime tradition, several pediatric cancer patients, along with their siblings and parents enjoyed an evening filled with exciting activities designed to give them a break from the stresses of cancer treatment.

08/27/2010: Palliative care

MGH Hotline 08.27.10 Integrating palliative care early in the treatment of advanced lung cancer not only improved patients' mood and quality of life, but also extended their lives.

08/25/2010: Targeted drug leads to rapid regression of metastatic melanoma in patients with mutated BRAF gene

Use of an experimental targeted drug to treat metastatic melanoma tumors with a specific genetic signature was successful in more than 80 percent of patients in a phase 1 clinical trial.

08/18/2010: Lung cancer patients receiving palliative care had improved quality of life, extended survival

Integrating palliative care early in the treatment of patients with advanced lung cancer not only improved their mood and quality of life, it also extended their lives.

08/06/2010: A special bond

MGH Hotline 08.06.10 This summer, one MGH physician traded his white coat for a suit jacket and his stethoscope for a wedding ceremony script when he officiated the wedding of one of his longtime patients.

08/04/2010: MicroRNA molecule increases number of blood stem cells, may help improve cancer treatment

MGH investigators have identified a new mechanism that controls the number of the stem cells that give rise to all blood and immune system cells, an advance that may improve treatment of blood system cancers.

07/23/2010: MGHfC honors amazing mothers

MGH Hotline 7.23.10 CANCER DOESN'T just affect the people diagnosed with it -- it affects entire families.

07/15/2010: Largest study of genomes and cancer treatments releases first results

The largest study to correlate genetics with response to cancer drugs releases its first results today. The researchers behind the study, based at the MGH Cancer Center and the Wellcome Trust Sanger Institute, describe the responses of 350 cancer samples to 18 anticancer therapeutics.

06/25/2010: Celebrating the one hundred

MGH Hotline 06.25.10 MORE THAN 650 guests attended the MGH Cancer Center’s annual fundraiser, the one hundred, held June 2 at the Westin Boston Waterfront.

06/18/2010: Cancer Center recognizes employees of the year

MGH Hotline 06.18.10 The MGH Cancer Center recognized not one but two individuals during this year’s employee of the year celebration.

06/18/2010: 2010 Claflin awards support six women researchers

MGH Hotline 06.18.10 Named for Jane D. Claflin, an honorary trustee who has championed women in academic medicine at the MGH, the Claflin Distinguished Scholar Awards are presented each year to outstanding women researchers who have the dual responsibility of caring for children.

06/15/2010: Combined BRAF-targeted and immunotherapy shows promise for melanoma treatment

Combined targeted therapy against the BRAF/MAPK pathway with immunotherapy shows promise as a new therapeutic approach for the treatment of melanoma, according to results of a preclinical study by MGH researchers.

06/03/2010: Study finds epigenetic similarities between Wilms tumor cells and normal kidney stem cells

A detailed analysis of the epigenetics – factors controlling when and where genes are expressed – of Wilms tumor reveals striking similarities to stem cells normally found in fetal kidneys. These findings by MGH Cancer Center researchers reveal new cellular pathways critical for Wilms tumor development that may apply to other pediatric cancers.

05/17/2010: Treatment reverses hearing loss in patients with neurofibromatosis type 2

Neurofibromatosis type 2 (NF2) is a genetic condition associated with bilateral vestibular schwannomas. It is rare, affecting only about one in 25,000 people.

05/15/2010: Avon Walk Boston supports research and care at Mass General

As part of the Eighth Annual Avon Walk Boston, the Avon Foundation awarded a generous research and patient care grant to Mass General's breast cancer program.

05/07/2010: In General awards and honors

MGH Hotline 5.07.10 In General awards and honors

05/04/2010: Sridhar Ramaswamy, MD, elected to the American Society of Clinical Investigation (ASCI)

The ASCI is an honor society of physician-scientists, who translate findings in the laboratory to the advancement of clinical practice.

04/18/2010: A Multidisciplinary Approach to Cancer Detection and Treatment: What’s On the Horizon

Cancer is a multifaceted disease that requires multiple approaches to diagnosis and management. At the American Association for Cancer Research 101st Annual Meeting 2010, scientists and clinicians will present more than 6,300 abstracts dealing with innovative aspects of biology, technology and emerging therapies.

04/16/2010: CUTS FOR A CAUSE

MGH Hotline 4.16.10 FOR THE THIRD YEAR IN A ROW, Boston Bruins players stepped into the "hot seat" -- or in this case, barber shop chairs -- to raise money for the Pediatric Hematology-Oncology Unit at MassGeneral Hospital for Children (MGHfC).

04/02/2010: Martin Research Award honorees

MGH Hotline 4.2.10 STUDIES REVEALING NETWORKS underlying key aspects of the immune system and describing a novel application of an antiangiogenesis drug were recognized with the second annual Joseph B. Martin Research Awards at the Feb. 24 Celebration of Science, held in conjunction with the Scientific Advisory Committee meeting.

04/01/2010: Treatment resistance in some cancer cells may be reversible

The ability of cancer cells to resist treatment with either targeted drug therapies or traditional chemotherapy may, in some cases, result from a transient state of reversible drug "tolerance."

03/31/2010: Improved device provides more rapid, comprehensive analysis of circulating tumor cells

Technical improvements to a microchip-based device for detecting and analyzing tumor cells in the bloodstream are revealing cellular differences that may reflect a tumor's aggressiveness and long-term response to treatment.

03/31/2010: Colorectal Screening Saves Lives

Colorectal cancer is the third leading cause of cancer death among men and women nationwide. But, if detected early colorectal cancer is treatable and beatable.

03/23/2010: A young mother battles a rare cancer

Sarcomas are malignant tumors that develop in muscle, bone, fat and other connective tissue in the human body. The Center for Sarcoma and Connective Tissue Oncology at the MGH Cancer Center is one of the few centers in the United States that specializes in the detection and treatment of these rare cancers. The Center is supported in part by the Jennifer Hunter Yates Sarcoma Foundation, which was established in honor of Yates, a patient at Mass General. Since 2005, the Foundation has raised nearly $600,000 and is helping patients from around the country battle this devastating disease.

03/21/2010: "Good" cells can go "bad" in a "bad neighborhood"

A new study by Harvard researchers at Massachusetts General Hospital indicates that “good” cells can become cancerous because of exposure to a “bad” environment within the body — similarly to the way a “good boy” may turn to crime when exposed to the pressures of life in a crime-ridden neighborhood.

03/19/2010: José Baselga, MD, PhD, joins MGH Cancer Center

MGH Hotline 3.19.10 RELOCATING FROM BARCELONA, Spain, to Boston, José Baselga, MD, PhD, chairman of the Medical Oncology Service and director of the Division of Medical Oncology, Hematology and Radiation Oncology at the Vall d'Hebron Institute of Oncology, will join the MGH this summer as chief of the Division of Hematology/Oncology and associate director of the MGH Cancer Center.

03/16/2010: Increased radiation dose does not increase long-term side effects for prostate cancer patients

Boosting the radiation dose given to prostate cancer patients to a level that cut recurrence in half did not increase the severity of side effects reported by patients up to a decade later. Patients also found the impact of continuing side effects on their quality of life to be less bothersome than would be expected, based on earlier studies.

03/11/2010: Possible ovarian cancer treatment target identified

A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer.

02/23/2010: Combined Mammography and Breast MRI Useful for Some High-Risk Women

Annual breast cancer screening with both mammography and magnetic resonance imaging is likely to be a cost-effective way to improve life expectancy in women with an increased risk of breast cancer.

02/01/2010: Radiation Oncology Safety at Mass General

An open letter to the Mass General community in response to national concerns about the safety of radiation delivery technology.

01/21/2010: Lack of cellular enzyme triggers switch in glucose processing

A study investigating how a cellular enzyme affects blood glucose levels in mice provides clues to pathways that may be involved in processes including the regulation of longevity and the proliferation of tumor cells.

01/05/2010: Landmark bone study addresses debilitating side effect of prostate cancer treatment

Vertebral fractures in men receiving androgen-deprivation therapy for prostate cancer are associated with pain, loss of mobility, and decreased survival.

12/18/2009: Cervical Cancer Screening

The American College of Obstetricians and Gynecologists (ACOG) recently released new guidelines for cervical cancer screening. Dr. Marcela Del Carmen from the Obstetrics and Gynecology Service and Dr. Elizabeth Roth from the Women’s Health Associates at Mass General help put this in context.

12/14/2009: Connecting the Dots

A team of researchers led by Daniel Haber, MD, PhD, director of the MGH Cancer Center, recently announced that they have revealed a unique molecular mechanism that might control the growth of cancer cells.

12/08/2009: Possible ovarian cancer treatment target identified

A multi-institutional study has identified a potential personalized treatment target for the most common form of ovarian cancer.

09/22/2009: New drug could significantly improve patient quality of life:

Matthew Smith, MD, PhD, of the Massachusetts General Hospital Cancer Center, led a study on a new targeted therapy to stop bone loss, increase bone density and prevent spinal fractures in men receiving androgen-deprivation therapy for prostate cancer.

08/24/2009: Minimally invasive surgery lessens pain of esophageal cancer

Christopher Morse, MD, of the Division of Thoracic Surgery at Massachusetts General Hospital has been able to remove esophageal tumors using an innovative minimally invasive procedure that offers patients less postoperative pain and a shorter recovery time

08/11/2009: Denosumab increases bone density, cuts fracture risk in prostate cancer survivors

Twice-yearly treatment with denosumab, a new targeted therapy to stop bone loss, increased bone density and prevented spinal fractures in men receiving androgen-deprivation therapy for prostate cancer.

07/15/2009: MGH study identifies first molecular steps to childhood leukemia

A Massachusetts General Hospital-based research team has identified how a chromosomal abnormality known to be associated with acute lymphoblastic leukemia – the most common cancer in children – initiates the disease process.

07/08/2009: Antiangiogenesis treatment improves hearing in some NF2 patients

Treatment with the angiogenesis inhibitor bevacizumab improved hearing and alleviated other symptoms in patients with neurofibromatosis type 2 (NF2). The study by researchers from Massachusetts General Hospital (MGH) represents the first report of a successful NF2 treatment not involving surgery or radiation.

06/22/2009: A New Milestone in the Fight Against Cancer

A landmark grant funds groundbreaking cancer research led by the Cancer Center to accelerate CTC-chip research, offering the potential to revolutionize how oncologists detect, monitor and treat cancers in the future.

06/12/2009: Celebrating the one hundred

MGH Hotline 06.12.09 It can be hard to quantify the emotional impact caregivers, researchers, donors, volunteers and advocates have on cancer patients and their families, but in many ways, the MGH Cancer Center’s the one hundred does just that.

06/05/2009: Employees of the year

MGH Hotline 6.5.09 Though in different departments, the winners of the MGH Cancer Center and the Radiation Oncology Department employee of the year awards have one thing in common: an outstanding ability to treat all patients with respect and kindness.

06/01/2009: Hitting where it hurts

A new study uncovers a gene expression signature that reliably identifies cancer cells whose survival is dependent on a common signaling pathway, even when the cells contain multiple other genetic abnormalities. The study from MGH Cancer Center researchers identifies critical molecular vulnerabilities, thereby revealing promising therapeutic targets for a common and notoriously treatment resistant cancer.

05/29/2009: MGH Cancer Center receives $15 million grant from SU2C

MGH Hotline 05.29.09 The MGH Cancer Center has been awarded a $15 million research grant from the proceeds raised by the landmark Sept. 5, 2008 Stand Up to Cancer (SU2C) telethon.

05/29/2009: In General awards and honors

MGH Hotline 05.29.09 In General awards and honors

05/22/2009: Michael Birrer, MD, PHd Elected to GCSC

Michael Birrer, MD, PhD, director of Massaschusetts General Hospital Cancer Center gynecologic medical oncology, has been elected as the new co-chair of the Gynecologic Cancer Steering Committee (GCSC).

05/22/2009: Jennifer Temel, MD Receives Palliative Care Grant Award

Jennifer Temel, MD has been awarded an American Cancer Society Pilot Project Support Grant.

05/22/2009: Avon Walk for Breast Cancer

The seventh annual Avon Walk for Breast Cancer, held in Boston the weekend of May 17, 2009, helped raise $5.6 million to advance access to care and finding a cure for breast cancer.

05/18/2009: Study examines trends in gallbladder cancer over 4 decades

Overall prognosis for gallbladder cancer appears to be improving, although many patients still have incurable disease and poor survival rates.

05/15/2009: Bernstein and Hochedlinger among 50 HHMI Early Career Scientists

MGH Hotline 5.15.09 Two MGH scientists — Bradley Bernstein, MD, PhD, of the Department of Pathology, and Konrad Hochedlinger, PhD, of the Center for Regenerative Medicine – are among the first group of Howard Hughes Medical Institute (HHMI) Early Career Scientists.

05/15/2009: The one hundred announced

MGH Hotline 5.15.09 Exactly 100 flowers were planted in the Howard Ufelder, MD, Healing Garden April 28 to recognize the newly announced members of the one hundred – 100 groups and individuals who are making a difference in cancer care.

05/04/2009: Screening the options: Dialogue an important part of prostate cancer screening and treatment

Prostate cancer experts at the Massachusetts General Hospital Cancer Center weigh in on best guidelines for screening.

04/13/2009: The Partnership Symposium: Conquering Breast Cancer

On Sunday, April 26, the 92nd Street Y in New York City brings together three of the leading breast cancer organizations, top scientists and researchers, and breast cancer survivors to provide clear and current information on the disease.

04/08/2009: Tiny sacs released by brain tumor cells carry information that may guide treatment

Exosomes deliver factors that promote tumor growth and may serve as blood biomarkers.

03/30/2009: Angiogenesis inhibitor improves brain tumor survival by reducing edema

The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily from reduction of edema – the swelling of brain tissue – and not from any direct anti-tumor effect.

03/23/2009: Her toughest opponent: Cathy and her team take on pancreatic cancer

Cathy partnered with Cancer Center physicians and staff to fight pancreatic cancer and regain her active lifestyle.

03/18/2009: Chemotherapy desensitization

What happens when you are allergic to a treatment that could save your life?

03/09/2009: Genetic profiling

Massachusetts General Hospital Cancer Center opens molecular pathology lab to genetically profile all patient tumors

03/06/2009: Both Latino and non-Latino women likely to accept HPV vaccination for selves and children

Most women responding to a survey conducted at MGH clinics indicated they would be willing to be vaccinated against the human papillomavirus and to have their daughters and even sons vaccinated in order to prevent cancer in their children. The report also found that Latino women are just as likely, if not more so, to accept HPV vaccine as non-Latinos.

03/06/2009: Personalizing cancer care

MGH Hotline 3.6.09 Cancer is most commonly classified by its location – in the lungs, liver, breast or elsewhere. In truth, however, every tumor is unique, and the genetic makeup of a tumor can often be more important than where it is located.

02/17/2009: New imaging technology shows promise in future cancer treatment

The first combined MRI/PET machine is being tested on brain cancer patients.

01/29/2009: MGH Cancer Center now offers pencil-beam proton therapy treatment

The MGH Cancer Center has added pencil-beam scanning to the radiation therapy modalities offered at the hospital’s Burr Proton Therapy Center.

01/23/2009: A gift in loving memory of a father

MGH Hotline 1.23.09When his father Kenneth died of a brain tumor at age 48 in 2005, then 17-year-old Justin Stanton knew he wanted to honor his father's memory in a way that would help others.

01/09/2009: Cancer genome research

The MGH Cancer Center and the Wellcome Trust Sanger Institute of the United Kingdom have begun a new alliance in cancer genome research.

01/09/2009: Erika Barrett, NP, honored

Erika Barrett, NP, of the MGH Cancer Center, recently was chosen the first recipient of the center's Hematology-Oncology Nurse Practitioner Excellence Award.

12/11/2008: Cancer Center Media Coverage

Browse news articles across local and national media outlets.

12/10/2008: Hormone therapy for prostate cancer does not appear to increase cardiac deaths

Treating prostate cancer patients with drugs that block hormonal activity does not appear to increase the risk of death from cardiovascular disease, according to a study led by MGH researchers

12/09/2008: Combining targeted therapy drugs may treat previously resistant tumors

Blocking two cell signaling pathways leads to dramatic shrinkage of K-Ras-mutated tumors in animal model

12/05/2008: In General

MGH Hotline: 12/05/08

12/05/2008: MGH Cancer Center staff visit Kazakhstan

MGH Hotline 12/05/08: A multidisciplinary team from the MGH Cancer Center recently traveled to Kazakhstan’s capitol Astana to work with the city’s Department of Health to improve the oncology services at a local hospital.

12/05/2008: MGH Cancer Center staff visit Kazakhstan

MGH Hotline 12/05/08 A multidisciplinary team from the MGH Cancer Center recently traveled to Kazakhstan’s capitol Astana to work with the city’s Department of Health to improve the oncology services at a local hospital.

12/05/2008: The fight against lung cancer lights up

MGH Hotline 12/5/08 Prudential Tower Hundreds of individuals supporting the fight against lung cancer joined special guests from the MGH, the Massachusetts chapter of the Lung Cancer Alliance, WCVB-TV’s Heather Unruh, and state public health and public policy leaders for a touching candlelight vigil at the Prudential Center Courtyard Nov. 20.

11/16/2008: Tiny sacs released by brain tumor cells carry information that may guide treatment

MGH researchers have found that tiny membrane-covered sacs released from glioblastoma cells contain molecules that may help guide treatment of the deadly brain tumor.

06/11/2008: Massachusetts General Hospital ranked on U.S. News national honor roll

The third oldest general hospital in the United States and the oldest and largest hospital in New England, Mass General continues its tradition of excellence today. The hospital is consistently ranked among the top five hospitals in the nation by U.S. News & World Report. In 2008, Mass General was redesignated a Magnet hospital, the highest honor for nursing excellence awarded by the American Nurses Credentialing Center.

04/18/2007: Sridhar Ramaswamy, MD, awarded the Sidney Kimmel Foundation Award in Translational Research

The Kimmel Scholar Awards were created in 1997 to further the careers of gifted, young scientists involved in cancer research.

02/01/2012: Advances in Cancer

Advances in Cancer: Winter 2012 edition
Advances in Cancer: Winter 2012 edition

09/01/2011: MGH Fund Update Summer 2011

View this publication
The MGH Fund Update is a publication for supporters of the MGH Fund, Mass General's fundamental resource for providing life-saving patient care, advancing biomedical research, and creating healthcare solutions in our community and around the globe.

06/09/2011: Advances in Cancer

Advances in Cancer: Spring 2011
Advances in Cancer: Spring 2011 edition

06/01/2011: Synergy Magazine: A Year in Review/A Look to the Future 2011

Synergy Magazine
Bold New Options: Pioneering the Next Generation of Cancer Care

01/07/2011: Advances in Cancer

Read Advances in Cancer
Advances in Cancer: Winter 2011 edition

01/01/2011: Advances at Mass General

Advances at Mass General, summer 2012 issue
Read Advances at Mass General, a bi-annual news magazine published for our colleagues from the physicians of Massachusetts General Hospital.

01/01/2011: Mass General Magazine

Read more at www.massgeneralmag.org
Mass General Magazine is a publication for supporters and friends of Massachusetts General Hospital that takes you inside the hospital and explores its patient care and research programs here and around the world. It features rich photo essays and in-depth profiles from across the Mass General world.

06/14/2010: Synergy Magazine: Spring 2010

Read Synergy Magazine
This issue, entitled "A year in review...a look to the future" highlights the Cancer Center's progress in understanding, preventing and curing cancer over the last year.

06/07/2010: Advances at the Mass General Cancer Center - Summer 2010

Advances at the Mass General Cancer Center - Summer 2010
Introducing ADVANCES at the MASS GENERAL CANCER CENTER, a new physician publication of the Massachusetts General Hospital Cancer Center. This newsletter will update you twice a year on how Mass General Cancer Center researchers and clinicians are helping to transform cancer care by approaching new thresholds in treatment that help us better understand the disease.
Subscribe to Advances at the Mass General Cancer Center

10/09/2009: Synergy Magazine: Fall 2009

Synergy: Fall 2009
This issue of Synergy focuses on sarcoma and soft tissue cancers.

04/01/2009: Proto: Dispatches from the frontiers of medicine

Proto magazine, Spring 2009 issue
The Spring 2009 issue of Proto, a magazine that reaches 75,000 thought leaders nationwide, explores new developments in organ transplantation, the relationship between public art and public health, creating stem cells from an unlikely source and the rollercoaster history of hormone replacement therapy.

01/01/2009: Proto: Dispatches from the frontiers of medicine

Proto magazine, Winter 2009 issue
The Winter 2009 issue of Proto, a magazine that reaches 75,000 thought leaders nationwide, features sociable robots, the model organism C. elegans, restorative neuroscience, micro medical practices and an elite set of HIV patients.

12/11/2008: A Guide to the Cancer Center for Patients and Families

View the PDF
A guide to treatment programs, as well as support, education and wellness services available to patients and families.

12/01/2008: Synergy

View this publication

07/01/2008: Synergy- Summer '08

View this publication
Synergy: Summer edition, 2008

12/12/2007: Journeys

View this publication
Massachusetts General Hospital Annual Report 2007

01/11/2007: Vision

View this publication
Vision is a magazine for the MGH community, donors and friends. In this issue read about the Massachusetts General Hosptial Cancer Center.

06/13/2015: 9th International Oncolytic Virus Therapeutics Conference

From June 13-16, 2015, two of the Harvard-affiliated institutions, Brigham and Women’s Hospital and Massachusetts General Hospital will host OVC Boston, the 9th International Oncolytic Virus Therapeutics Conference at the historic Boston Park Plaza Hotel.

04/28/2014: An Evening Program for Women Living with Cancer

Please join us on April 28th as author and GYN patient Katya Lezin discusses her book But I Just Grew Out My Bangs! A Cancer Tale.

04/12/2014: Through Each Other’s Eyes: Sharing What We’ve Learned From Living With Cancer

Please join us for our annual survivorship conference

07/27/2013: Ovarian Cancer Survivors Course

A FREE full-day course for all cancer survivors, family members, friends and others.

07/18/2013: Young Adult Conference

A FREE conference for patients 16-24 years of age (on treatment or within five years of treatment)

07/17/2013: Brian D. Silber Memorial Golf Tournament

The 16th annual Brian D. Silber Memorial Golf Tournament will be held on July 17, 2013. Golf Tournament is at The Meadow at Peabody Golf Course, Peabody, MA. Dinner Reception is at the Hilltop Steak House, Saugus, MA.

06/20/2013: The Patty Fund Golf Outing

The Bevis Family and The Patty Fund are hosting a golf tournament to benefit Brain Cancer research at Mass General.

06/05/2013: the one hundred 2013

Join us on June 5 for the 6th annual the one hundred event!

05/26/2013: 2013 Boston Run to Remember

Dr. Lipika Goyal is participating in Boston's Run to Remember in honor of her patient, Maria Efstratoudakis, who died from cholangiocarcinoma.

05/18/2013: Caring for a Cure

Join the nurses of Lunder-10 and Cox-1 for the Marshfield 5K!



07/28/2012: Women's Cancer's 2012 Ovarian Cancer Survivors Course

Please join us for a free, full day course for all cancer survivors, friends, family members and others.

Cancer Breakthroughs

Research at Mass General leads to breakthroughs in cancer treatment and prevention.

Illuminations February - May 2010

View images from the Illuminations February - May 2010 exhibition.

Genotyping and Targeted Therapies Radio Ad

David P. Ryan, MD, clinical director of the Cancer Center and Tucker Gosnell Center for Gastrointestinal Cancers talks about targeted therapies and genetic testing at the Cancer Center.

Illuminations: June - September 2010

View images from the Illuminations June - September 2010 exhibition.

Trailer for Boston Med

Trailer for the eight-part documentary featuring clinicians at Mass General.

The Katharine A. Gallagher Integrative Therapies Program: Expressive Arts Therapy

With support from our art therapist, creative activities like making a collage, painting or writing can help people with cancer feel better. Art therapy can help them reduce stress, provide a way to express their feelings and develop coping skills to manage their cancer journey. "Creating art is wonderful therapy. It is very relaxing and helps me work through my feelings about cancer." - Patient with cancer

The Katharine A. Gallagher Integrative Therapies Program: Music Therapy

By making music, listening to music or composing songs with our music therapist people with cancer can develop skills to help them through their cancer experience. Music therapy provides an outlet for their emotions, and can help reduce stress, decrease side effects like nausea and manage pain. “My daughter told me that while she was playing music with you, she didn't feel the pain at all. So please keep doing what you are doing and know that you do make a difference.” - Mom of patient with cancer

Translational Research Lab (TRL)

The Massachusetts General Hospital Cancer Center is committed to advancing oncology care by tailoring treatment options to the individual cancer patient. The basic mission of the Translational Research Laboratory (TRL) is to provide rapid personalized genomic testing as an important component of routine care, thereby minimizing generalizations made in treatment decisions.

Hensin Tsao, MD, recommends what you can do to protect your family from melanoma

Hensin Tsao, MD, Director of Mass General's Melanoma and Pigmented Lesion Center explains how family history, genetic risks and personal health history can all affect your risk of melanoma, and what steps you should take to detect it at an early, treatable stage.

Marcela Del Carmen, MD, talks about your risk of developing cervical cancer, even as you age

Marcela Del Carmen, MD, a gynecologic oncologist at the Massachusetts General Hospital Cancer Center says that the risk for cervical cancer goes up, not down, as you age. Learn about your risk for cervical cancer, and the new guidelines that caution women to continue to get PAP smears into their 60s.

Alice Shaw, MD, explains why patients with lung cancer can benefit from genetic testing

Alice Shaw, MD, thoracic oncologist at the Mass General Cancer Center, says patients with lung cancer can benefit from genetic testing, particularly if they are young non-smokers. Learn more about personalized treatment for lung cancer and new "smart drugs" that target a tumor's specific genetic mutation to slow the cancer's growth, and in some cases, reduce it significantly.

Hensin Tsao, MD recommends what you can do to protect your family from melanoma

Hensin Tsao, MD, Director of Mass General's Melanoma and Pigmented Lesion Center explains how family history, genetic risks and personal health history can all affect your risk of melanoma, and what steps you should take to detect it at an early, treatable stage.

Illuminations: October - January, 2010

View images from the Illuminations October - January 2010 exhibition.

Campaign for the Third Century of MGH Medicine Kick Off on October 15

The Campaign for the Third Century of MGH Medicine kicked off Oct. 15 at the Westin Waterfront Boston. Nearly 500 of Mass General’s closest friends and supporters gathered to celebrate the public launch of the fundraising campaign that aims to raise $1.5 billion for the hospital. Already, $1 billion of that amount has been raised.

Bill Schuette's Story

Watch Bill Schuette tell the story of why he drove 18 hours each way from Ohio for lung cancer treatment at the Mass General Cancer Center.

Researchers hone in on treatment targets for ovarian cancer

Gynecologic cancer research Program Director Michael Birrer, MD, PhD, explains how ovarian tumor discoveries in the lab are already impacting patient care.

Celebrating 200 Years: 1811 - 2011

Since 1811, people have counted on Mass General for answers, innovations and medical leadership. As our third century dawns, we remain ready to serve.

I'm Still Here: Pancreatic Cancer Survivor

Pancreatic cancer patients at the Massachusetts General Hospital Cancer Center benefit from the innovative work of The Andrew L. Warshaw Institute for Pancreatic Cancer Research which includes a community of scientists, oncologists, surgeons, radiation oncologists and interventional endoscopists whose mission is to extend and improve the lives of patients with pancreatic cancer.

Illuminations: February - May, 2011

View images from the Illuminations February - May, 2011 exhibition.

Illuminations: June - September 2011: Part I

View images from the Illuminations June - September 2011 exhibition.

Illuminations: June - September 2011 Part II

View images from the Illuminations June - September 2011 exhibit.

About Radiation Therapy Treatment at MGH

An introduction to the Department of Radiation Oncology at Massachusetts General Hospital. An overview of the different processes and procedures to expect in the course of your treatment program. Learn about what radiation is and the different types of radiation used to treat cancer.

Anne Buckless, 2012 Mass General Marathon Team Runner

After meeting the Mass General Marathon Team last year, Anne couldn’t say no when they asked her to join in 2012, and she’s running in honor of Helen, age 5, one of the patient-partners.

Ali Reeder, 2012 Mass General Marathon Team Runner

Running her third marathon, Ali runs "for the people who can't" — the pediatric patients that the Mass General Marathon Team benefits.

Antoine Tanne, 2012 Mass General Marathon Team Runner

A researcher at Mass General, Antoine is looking forward to Marathon Monday, when he’ll celebrate both his first marathon, and the end of treatment for his patient-partner, Michael.

Bruce Kalow, 2012 Mass General Marathon Team Runner

A pediatrician at Mass General, Bruce sees first-hand the remarkable care available to young cancer patients. With the support of friends and donors, diseases like leukemia are incredibly treatable, giving his patients great prognoses.

Chris Buligax, 2012 Mass General Marathon Team Runner

Chris is running his first marathon for his son, Nathan. He and his family have experienced the many amazing programs offered through the MassGeneral Hospital for Children Pediatric Hematology-Oncology program.

Delia Rissmiller, 2012 Mass General Marathon Team Runner

A 3-time marathoner, Delia is running in honor and in memory of her father’s battle with lymphoma. She says it’s her “little way of giving back to a place that gave so much to him and to my family.”

Howard Weinstein, 2012 Mass General Marathon Team Runner

As founder and captain of the Mass General Marathon Team and chief of Pediatric Hematology-Oncology, Howard is running his 22nd Boston Marathon and his15th marathon to fight pediatric cancer. This year, he’s running in honor of his patient-partner, Lily.

Greg Gonzales, 2012 Mass General Marathon Team Runner

As a veteran of the Mass General Marathon Team, he rose to the challenge his mother, a Mass General nurse, presented to him five years ago to start running marathons. His patient-partner, Matthew, continues to provide the inspiration necessary to keep running.

Jenna Norton, 2012 Mass General Marathon Team Runner

Jenna started running three years ago, when she lost her father to his fight against cancer. His passing inspired her to become healthier — watch her video to learn just how much her life changed when she started running.

Jonathan Friedstat, 2012 Mass General Marathon Team Runner

As a burn and critical care fellow at Mass General, Jonathan has worked closely with MGHfC staff. Why is he running to raise money for pediatric cancer care and research? “None of these kids asked for this problem, and neither did their families."

Marisa Levine, 2012 Mass General Marathon Team Runner

Marisa Levine, a Mass General employee, is running her first marathon in honor of her patient-partner, Lizany, and in memory of Eric, a close friend who passed away from leukemia.

Sarah Visocchi, 2012 Mass General Marathon Team Runner

Sarah is running in memory of her father and in honor of her patient-partner, Emma, age 8. She shares her thoughts on the many impressive programs available for pediatric cancer patients at Mass General, and the need for philanthropic support to ensure kids have access to these programs during challenging times.

Cancer Survivors Strut Down the Runway

Neiman Marcus and the Mass General Cancer Center held a fashion show March 29 at Neiman Marcus in Copley Place to celebrate cancer survivors, gathering members of the Mass General Cancer Center community. During the RUNWAY TEN event physicians, nurses and patients walked the runway in Spring 2012 styles reminding everyone that the work done in patient care and research helps more people live happy and healthy lives after cancer. (photographs by Laura Widness)

Screening for lymphedema with a Perometer

Doctors at Massachusetts General Hospital Cancer Center are using a Perometer to detect breast cancer-related lymphedema.

John Murphy

John Murphy has an amazing story to tell. Listen to his story and learn about advances in targeted cancer therapies that are bringing new hope to patients. With the opening of the Henri and Belinda Termeer Center for Targeted Therapies, the Mass General Cancer Center is expanding its phase one clinical trials program to help more patients like him.

Dr. Keith Flaherty

Dr. Keith Flaherty is the director of the Henri and Belinda Termeer Center for Targeted Therapies. Dr. Flaherty and his exceptional team of clinicians and scientists are spearheading research into promising new treatment options for patients through phase I clinical investigation.

Termeer Center Opening Symposium

On Oct. 2, 2012, Mass General Cancer Center Director Dr. Daniel Haber hosted an educational symposium to introduce the Termeer Center. Dr. Robert Weinberg of MIT, Dr. José Baselga of Memorial Sloan-Kettering, and Mass General Cancer Center’s own Drs. Keith Flaherty and Jeff Engelman presented to an audience of 125 in the Ether Dome.

Termeer Center Opening Reception

Following the Oct. 2 symposium, a celebratory reception was held in the Termeer Center on Yawkey 7. Hear inspiring remarks by MGH President Dr. Peter Slavin, Mass General Cancer Center Director Dr. Daniel Haber, Termeer Center Director Dr. Keith Flaherty, patient John Murphy and donor Henri Termeer. The reception concluded with a ribbon-cutting.

The Economics of Cancer

On Dec. 13 Mass General Cancer Center hosted the Economics of Cancer. This video features introductory remarks by Drs. Daniel Haber and Phillip Sharp, and Dr. David Cutler’s keynote presentation, “Health Reform and Cancer: Who Will Pay for New Targeted Therapies?” Dr. Cutler is the Otto Eckstein Professor of Applied Economics at Harvard University.


Request an appointment at the Cancer Center

Contact the Cancer Center to schedule an appointment with one of our cancer specialists

Make a gift

Your gift of any amount will open new doors in outstanding patient care, research, clinical education and community outreach at Mass General.